Oncogene (journal)

Oncogene is a peer-reviewed scientific journal that publishes research articles related to the field of oncology. The journal focuses on the cellular and molecular pathways of cancer cells, and its primary aim is to publish original research, reviews, and commentaries that elucidate the molecular mechanisms responsible for cancer development and progression.

History[edit | edit source]

The journal Oncogene was first published in 1987. Since its inception, it has been a leading source of information for researchers in the field of oncology. The journal is published by the Nature Publishing Group, a division of Springer Nature, which is known for its high-quality scientific publications.

Scope[edit | edit source]

Oncogene covers a broad range of topics related to cancer research, including but not limited to, the molecular basis of cancer, cell cycle regulation, cell growth, apoptosis, cell differentiation, DNA repair, genetic instability, microRNAs, epigenetics, cancer genetics, cancer genomics, cancer proteomics, cancer immunology, cancer stem cells, metastasis, angiogenesis, cancer therapeutics, and cancer prevention.

Impact Factor[edit | edit source]

The Impact factor of Oncogene is a measure of the frequency with which the average article in the journal has been cited in a particular year. As of 2020, the journal has an impact factor of 7.971, indicating its significant influence in the field of oncology.

Editorial Board[edit | edit source]

The editorial board of Oncogene consists of eminent scientists and researchers from around the world, who are experts in various aspects of oncology. The board is responsible for maintaining the high scientific standards of the journal and ensuring that only the most significant and rigorous research is published.

Submission and Review Process[edit | edit source]

Oncogene follows a stringent peer review process to ensure the quality and validity of the research it publishes. Manuscripts submitted to the journal are initially screened by the editorial team and those deemed suitable are sent for review to at least two independent experts in the field.